AccuStem Sciences, Inc. ACUT
Set alert
At close · Oct 29
- YTD
- -84.02%
- 1 year
- -89.52%
- Open
- 0.15
- Prev close
- 0.15
- Mkt cap
- 2.09M
- Vol
- 4
- Avg vol
- 2.68K
- EPS
- -0.11
- P/E
- 0.00
More statistics
- Low
- 0.15
- High
- 0.15
5D chart
Signals (10)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 29, 12:50 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 11:40 AM | 2 days ago |
| RSI: Oversold | Oct 29, 11:40 AM | 2 days ago |
| MACD: Buy Signal | Oct 27, 12:00 PM | 4 days ago |
| SMA: Bearish | Oct 27, 10:45 AM | 4 days ago |
| SMA: Bearish | Oct 27, 10:45 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 10:45 AM | 4 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 5 days ago |
| RSI: Overbought | Oct 26, 3:55 PM | 5 days ago |
News
9 months ago globenewswire.com
AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP)
PHOENIX, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, today…
1 year ago globenewswire.com
AccuStem Sciences and EmeritusDX Expand Blood-Based Testing Capabilities to Advance Cancer Diagnostics and Treatment Planning
PHOENIX, Ariz. and LONDON, Sept.
1 year ago globenewswire.com
AccuStem Sciences to Present at the Life Sciences Virtual Investor Forum September 18th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as…
1 year ago globenewswire.com
AccuStem Sciences to Present at the Life Sciences Virtual Investor Forum September 18th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as…
1 year ago globenewswire.com
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
LONDON and PHOENIX, June 16, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced…
1 year ago globenewswire.com
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
LONDON, June 13, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its…
1 year ago globenewswire.com
AccuStem Sciences, Inc. and EmeritusDX Announce Partnership to Commercialize MSC Test for Lung Cancer Screening
LONDON and PHOENIX, Ariz., April 28, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk…
1 year ago globenewswire.com
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
LONDON and PHOENIX, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer,…
1 year ago globenewswire.com
AccuStem Sciences, Inc. Signs Agreement to Access Blood Samples from Lung Cancer Screening Trial to Expedite MSC Commercialization Plan
LONDON and PHOENIX, April 16, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of…
1 year ago globenewswire.com
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
LONDON and PHOENIX, April 10, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced…
1 year ago globenewswire.com
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
LONDON and PHOENIX, April 08, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced…
1 year ago globenewswire.com
AccuStem Sciences to Offer its MSC Blood Test to Lung Cancer Screening Programs in the United States
LONDON and PHOENIX, April 04, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of…
1 year ago globenewswire.com
AccuStem Sciences, Inc. Announces Acquisition of Proprietary MSC Lung Cancer Screening Test
AccuStem pursuing strategic commercialization plan intending to launch the MSC test in the US in 2026 LONDON and PHOENIX, Ariz., March 18, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB:…
1 year ago globenewswire.com
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
LONDON and PHOENIX, Jan. 03, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced…
3 years ago globenewswire.com
AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership
LONDON and PHOENIX, July 17, 2023 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, and…
3 years ago globenewswire.com
AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer
LONDON and PHOENIX, July 11, 2023 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, signs…